BACKGROUND: The Walking Impairment Questionnaire (WIQ) is a subjective measure of patient-reported walking performance developed for peripheral arterial disease. The purpose of this study is to examine whether this simple tool can improve the predictive capacity of established risk models and whether the WIQ can be used in patients without peripheral arterial disease. METHODS AND RESULTS: At baseline we assessed the walking distance, stair-climbing, and walking speed WIQ category scores among individuals who were undergoing coronary angiography. During a median follow-up of 5.0 years, there were 172 mortalities among 1417 study participants. Adjusted Cox proportional hazards models showed that all 3 WIQ categories independently predicted future all-cause and cardiovascular mortality, including among individuals without peripheral arterial disease (P<0.001). Compared with the cardiovascular risk factors model, we observed significantly increased risk discrimination with a C-index of 0.741 (change in C-index, 0.040; 95% confidence interval, 0.011-0.068) and 0.832 (change in C-index, 0.080; 95% confidence interval, 0.034-0.126) for all-cause and cardiovascular mortality, respectively. Examination of risk reclassification using the net reclassification improvement index showed a 48.4% (P<0.001) improvement for all-cause mortality and a 77.4% (P<0.001) improvement for cardiovascular mortality compared with the cardiovascular risk factors model. CONCLUSIONS: All 3 WIQ categories independently predicted future all-cause and cardiovascular mortality. Importantly, we found that this subjective measure of walking ability could be extended to patients without peripheral arterial disease. The addition of the WIQ scores to established cardiovascular risk models significantly improved risk discrimination and reclassification, suggesting broad clinical use for this simple, inexpensive test.
BACKGROUND: The Walking Impairment Questionnaire (WIQ) is a subjective measure of patient-reported walking performance developed for peripheral arterial disease. The purpose of this study is to examine whether this simple tool can improve the predictive capacity of established risk models and whether the WIQ can be used in patients without peripheral arterial disease. METHODS AND RESULTS: At baseline we assessed the walking distance, stair-climbing, and walking speed WIQ category scores among individuals who were undergoing coronary angiography. During a median follow-up of 5.0 years, there were 172 mortalities among 1417 study participants. Adjusted Cox proportional hazards models showed that all 3 WIQ categories independently predicted future all-cause and cardiovascular mortality, including among individuals without peripheral arterial disease (P<0.001). Compared with the cardiovascular risk factors model, we observed significantly increased risk discrimination with a C-index of 0.741 (change in C-index, 0.040; 95% confidence interval, 0.011-0.068) and 0.832 (change in C-index, 0.080; 95% confidence interval, 0.034-0.126) for all-cause and cardiovascular mortality, respectively. Examination of risk reclassification using the net reclassification improvement index showed a 48.4% (P<0.001) improvement for all-cause mortality and a 77.4% (P<0.001) improvement for cardiovascular mortality compared with the cardiovascular risk factors model. CONCLUSIONS:All 3 WIQ categories independently predicted future all-cause and cardiovascular mortality. Importantly, we found that this subjective measure of walking ability could be extended to patients without peripheral arterial disease. The addition of the WIQ scores to established cardiovascular risk models significantly improved risk discrimination and reclassification, suggesting broad clinical use for this simple, inexpensive test.
Authors: Mark A Creager; Michael Belkin; Edward I Bluth; Donald E Casey; Seemant Chaturvedi; Michael D Dake; Jerome L Fleg; Alan T Hirsch; Michael R Jaff; John A Kern; David J Malenka; Edward T Martin; Emile R Mohler; Timothy Murphy; Jeffrey W Olin; Judith G Regensteiner; Robert H Rosenwasser; Peter Sheehan; Kerry J Stewart; Diane Treat-Jacobson; Gilbert R Upchurch; Christopher J White; Jack A Ziffer Journal: J Am Coll Cardiol Date: 2011-12-05 Impact factor: 24.094
Authors: Amir H Sadrzadeh Rafie; Marcia L Stefanick; Stacy T Sims; Tiffany Phan; Mamie Higgins; Andre Gabriel; Themistocles Assimes; Balasubramanian Narasimhan; Kevin T Nead; Jonathan Myers; Jeffrey Olin; John P Cooke Journal: Vasc Med Date: 2010-12 Impact factor: 3.239
Authors: Donald Lloyd-Jones; Robert J Adams; Todd M Brown; Mercedes Carnethon; Shifan Dai; Giovanni De Simone; T Bruce Ferguson; Earl Ford; Karen Furie; Cathleen Gillespie; Alan Go; Kurt Greenlund; Nancy Haase; Susan Hailpern; P Michael Ho; Virginia Howard; Brett Kissela; Steven Kittner; Daniel Lackland; Lynda Lisabeth; Ariane Marelli; Mary M McDermott; James Meigs; Dariush Mozaffarian; Michael Mussolino; Graham Nichol; Véronique L Roger; Wayne Rosamond; Ralph Sacco; Paul Sorlie; Véronique L Roger; Randall Stafford; Thomas Thom; Sylvia Wasserthiel-Smoller; Nathan D Wong; Judith Wylie-Rosett Journal: Circulation Date: 2009-12-17 Impact factor: 29.690
Authors: Stephanie Studenski; Subashan Perera; Kushang Patel; Caterina Rosano; Kimberly Faulkner; Marco Inzitari; Jennifer Brach; Julie Chandler; Peggy Cawthon; Elizabeth Barrett Connor; Michael Nevitt; Marjolein Visser; Stephen Kritchevsky; Stefania Badinelli; Tamara Harris; Anne B Newman; Jane Cauley; Luigi Ferrucci; Jack Guralnik Journal: JAMA Date: 2011-01-05 Impact factor: 56.272
Authors: Atul Jain; Kiang Liu; Luigi Ferrucci; Michael H Criqui; Lu Tian; Jack M Guralnik; Huimin Tao; Mary M McDermott Journal: J Vasc Surg Date: 2012-06 Impact factor: 4.268
Authors: Andrew M Wilson; Amir H Sadrzadeh-Rafie; Jonathan Myers; Themistocles Assimes; Kevin T Nead; Mamie Higgins; Andre Gabriel; Jeffrey Olin; John P Cooke Journal: J Vasc Surg Date: 2011-06-12 Impact factor: 4.268
Authors: Nicholas J Leeper; Azad Raiesdana; Yoko Kojima; Ramendra K Kundu; Henry Cheng; Lars Maegdefessel; Ryuji Toh; G-One Ahn; Ziad A Ali; D Ryan Anderson; Clint L Miller; Scott C Roberts; Joshua M Spin; Patricia E de Almeida; Joseph C Wu; Baohui Xu; Karen Cheng; Maximilian Quertermous; Soumajit Kundu; Kim E Kortekaas; Erica Berzin; Kelly P Downing; Ronald L Dalman; Philip S Tsao; Eric E Schadt; Gary K Owens; Thomas Quertermous Journal: Arterioscler Thromb Vasc Biol Date: 2012-11-15 Impact factor: 8.311
Authors: Xinsong Du; Jae Min; Chintan P Shah; Rohit Bishnoi; William R Hogan; Dominick J Lemas Journal: Int J Med Inform Date: 2020-04-15 Impact factor: 4.046
Authors: Manesh R Patel; Michael S Conte; Donald E Cutlip; Nabil Dib; Patrick Geraghty; William Gray; William R Hiatt; Mami Ho; Koji Ikeda; Fumiaki Ikeno; Michael R Jaff; W Schuyler Jones; Masayuki Kawahara; Robert A Lookstein; Roxana Mehran; Sanjay Misra; Lars Norgren; Jeffrey W Olin; Thomas J Povsic; Kenneth Rosenfield; John Rundback; Fadi Shamoun; James Tcheng; Thomas T Tsai; Yuka Suzuki; Pascal Vranckx; Bret N Wiechmann; Christopher J White; Hiroyoshi Yokoi; Mitchell W Krucoff Journal: J Am Coll Cardiol Date: 2015-03-10 Impact factor: 24.094
Authors: Kelly P Downing; Kevin T Nead; Yoko Kojima; Themistocles Assimes; Lars Maegdefessel; Thomas Quertermous; John P Cooke; Nicholas J Leeper Journal: Vasc Med Date: 2013-12-09 Impact factor: 3.239
Authors: Alyssa M Flores; Alejandro Schuler; Anne Verena Eberhard; Jeffrey W Olin; John P Cooke; Nicholas J Leeper; Nigam H Shah; Elsie G Ross Journal: J Am Heart Assoc Date: 2021-11-30 Impact factor: 6.106
Authors: Dylan R Morris; Alexander J Rodriguez; Joseph V Moxon; Margaret A Cunningham; Mary M McDermott; Jonathan Myers; Nicholas J Leeper; Rhondda E Jones; Jonathan Golledge Journal: J Am Heart Assoc Date: 2014-08-13 Impact factor: 5.501
Authors: Kate Levenberg; David N Proctor; Stephan R Maman; J Carter Luck; Amanda J Miller; Faisal Aziz; John F Radtka; Matthew D Muller Journal: SAGE Open Med Date: 2020-06-13